Data gathered: June 18
AI Stock Analysis - Integra Lifesciences (IART)
Analysis generated March 3, 2024. Powered by Chat GPT.
Integra Lifesciences is a global leader in medical technology with a focus on neurosurgery, reconstructive and general surgery, and extremities solutions. The company designs, manufactures, and markets products that are utilized in a broad range of applications from brain to skin, enhancing the quality of life for patients and improving the practice of surgeons around the world. By providing innovative and quality products and services, Integra Lifesciences aims to remain at the forefront of medical technologies.
Stock Alerts - Integra Lifesciences (IART)
 |
Integra Lifesciences | June 14 Over the past few months, there has been a noticeable downward trend in Job postings. |
|
Integra Lifesciences | June 11 Price is down by -7.4% in the last 24h. |
|
Integra Lifesciences | June 10 Job postings are down by 20.9% in the last couple of days. |
|
Integra Lifesciences | June 3 Price is up by 7.1% in the last 24h. |
Download our app to get future alerts delivered in real-time.
Alternative Data for Integra Lifesciences
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 147 | Sign up | Sign up | Sign up |
| Sentiment | 100 | Sign up | Sign up | Sign up |
| Webpage traffic | 93,000 | Sign up | Sign up | Sign up |
| Employee Rating | 60 | Sign up | Sign up | Sign up |
| Google Trends | 29 | Sign up | Sign up | Sign up |
| Patents | 60 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | 2 | Sign up | Sign up | Sign up |
| Facebook Followers | 1,118 | Sign up | Sign up | Sign up |
| Instagram Followers | 1,902 | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 1 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 352 | Sign up | Sign up | Sign up |
| Twitter Followers | 2,051 | Sign up | Sign up | Sign up |
| Twitter Mentions | N/A | Sign up | Sign up | Sign up |
| News Mentions | 2 | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 28 | Sign up | Sign up | Sign up |
| Linkedin Employees | 3,876 | Sign up | Sign up | Sign up |
About Integra Lifesciences
Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical products, and wound care products for use in neurosurgery, neurocritical care and otolaryngology.
| Price | $12.32 |
| Target Price | Sign up |
| Volume | 81,720 |
| Market Cap | $963M |
| Year Range | $12.15 - $26.7 |
| Dividend Yield | 0% |
| PE Ratio | 83.17 |
| Analyst Rating | 13% buy |
| Industry | Medical Devices |
In the news
 |
Integra LifeSciences Holdings Co. (NASDAQ:IART) Receives $18.63 Consensus PT from AnalystsJune 16 - ETF Daily News |
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Integra LifeSciences Holdings Corporation - IARTJune 16 - Finnhub |
|
|
Analyzing Integra LifeSciences (NASDAQ:IART) and Arch Therapeutics (OTCMKTS:ARTH)June 15 - ETF Daily News |
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Integra LifeSciences Holdings Corporation - IARTJune 6 - GlobeNewswire |
|
|
Integra LifeSciences Holdings Co. (NASDAQ:IART) Shares Sold by Squarepoint Ops LLCJune 4 - ETF Daily News |
 |
Integra (IART) Up 2.3% Since Last Earnings Report: Can It Continue?June 4 - Yahoo |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q1 '25 | 383M | 188M | 383M | -25M | -15M | -0.331 |
| Q4 '24 | 443M | 194M | 249M | 19M | 82M | 0.970 |
| Q3 '24 | 381M | 181M | 200M | -11M | 39M | 0.410 |
| Q2 '24 | 418M | 186M | 232M | -12M | 45M | 0.630 |
| Q1 '24 | 369M | 162M | 207M | -3.3M | 71M | 0.550 |
Insider Transactions View All
| Schwartz Eric filed to sell 59,511 shares at $24.6. December 4 '24 |
| McBreen Michael J. filed to sell 56,182 shares at $24.2. December 3 '24 |
| Mosebrook Jeffrey filed to sell 36,088 shares at $21.6. August 20 '24 |
| ESSIG STUART filed to buy 487,922 shares at $28.5. May 24 '24 |
| HILL BARBARA B filed to buy 36,350 shares at $27.4. May 22 '24 |
Similar companies
Congress Trading View All
| Politician | Filing Date | Type | Size |
|---|---|---|---|
| Josh Gottheimer |
Jul 9, 24 | Sell | $1K - $15K |
| Joshua Gottheimer Democrat |
May 15, 24 | Sell | $1K - $15K |
| Joshua Gottheimer Democrat |
Nov 11, 23 | Buy | $1K - $15K |
Read more about Integra Lifesciences (IART) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of Integra Lifesciences?
The Market Cap of Integra Lifesciences is $963M.
What is Integra Lifesciences' PE Ratio?
As of today, Integra Lifesciences' PE (Price to Earnings) ratio is 83.17.
What is the current stock price of Integra Lifesciences?
Currently, the price of one share of Integra Lifesciences stock is $12.32.
How can I analyze the IART stock price chart for investment decisions?
The IART stock price chart above provides a comprehensive visual representation of Integra Lifesciences' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Integra Lifesciences shares. Our platform offers an up-to-date IART stock price chart, along with technical data analysis and alternative data insights.
Does IART offer dividends to its shareholders?
As of our latest update, Integra Lifesciences (IART) does not offer dividends to its shareholders. Investors interested in Integra Lifesciences should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Integra Lifesciences?
Some of the similar stocks of Integra Lifesciences are Boston Scientific, Edwards Lifesciences, Intuitive Surgical, Medtronic, and Stryker.
.